Earnings Call · Q2 FY2021·2021-08-07

Q2 21EPS -2.00%·Rev n/aQ1 21EPS -9.52%·Rev n/aQ4 20EPS 0.00%·Rev n/aQ3 20EPS -5.00%·Rev n/a⚠ consensus missing

Kura Oncology, Inc. KURA

Pete De Spain — Vice President of Investor Relations

Troy Wilson — President and Chief Executive Officer

Marc Grasso — Chief Financial Officer and Chief Business Officer

+4.1%1d on move date+3.5% vs SPY3d−1.8%5d−3.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KURA calls or request research access.

More KURA calls Browse calls Request research access